2024-09-012025-08-312025-08-31falseSC572929THE EYE CLINIC (SCOTLAND) LTD2026-05-3186220falseiso4217:GBPxbrli:pureSC5729292024-08-31SC5729292025-08-31SC5729292024-09-012025-08-31SC5729292023-08-31SC5729292024-08-31SC5729292023-09-012024-08-31SC572929bus:SmallEntities2024-09-012025-08-31SC572929bus:AuditExempt-NoAccountantsReport2024-09-012025-08-31SC572929bus:FullAccounts2024-09-012025-08-31SC572929bus:PrivateLimitedCompanyLtd2024-09-012025-08-31SC572929core:WithinOneYear2025-08-31SC572929core:AfterOneYear2025-08-31SC572929core:WithinOneYear2024-08-31SC572929core:AfterOneYear2024-08-31SC572929core:ShareCapital2025-08-31SC572929core:SharePremium2025-08-31SC572929core:RevaluationReserve2025-08-31SC572929core:OtherReservesSubtotal2025-08-31SC572929core:RetainedEarningsAccumulatedLosses2025-08-31SC572929core:ShareCapital2024-08-31SC572929core:SharePremium2024-08-31SC572929core:RevaluationReserve2024-08-31SC572929core:OtherReservesSubtotal2024-08-31SC572929core:RetainedEarningsAccumulatedLosses2024-08-31SC572929core:LandBuildings2025-08-31SC572929core:PlantMachinery2025-08-31SC572929core:Vehicles2025-08-31SC572929core:FurnitureFittings2025-08-31SC572929core:OfficeEquipment2025-08-31SC572929core:NetGoodwill2025-08-31SC572929core:IntangibleAssetsOtherThanGoodwill2025-08-31SC572929core:ListedExchangeTraded2025-08-31SC572929core:UnlistedNon-exchangeTraded2025-08-31SC572929core:LandBuildings2024-08-31SC572929core:PlantMachinery2024-08-31SC572929core:Vehicles2024-08-31SC572929core:FurnitureFittings2024-08-31SC572929core:OfficeEquipment2024-08-31SC572929core:NetGoodwill2024-08-31SC572929core:IntangibleAssetsOtherThanGoodwill2024-08-31SC572929core:ListedExchangeTraded2024-08-31SC572929core:UnlistedNon-exchangeTraded2024-08-31SC572929core:LandBuildings2024-09-012025-08-31SC572929core:PlantMachinery2024-09-012025-08-31SC572929core:Vehicles2024-09-012025-08-31SC572929core:FurnitureFittings2024-09-012025-08-31SC572929core:OfficeEquipment2024-09-012025-08-31SC572929core:NetGoodwill2024-09-012025-08-31SC572929core:IntangibleAssetsOtherThanGoodwill2024-09-012025-08-31SC572929core:ListedExchangeTraded2024-09-012025-08-31SC572929core:UnlistedNon-exchangeTraded2024-09-012025-08-31SC572929core:MoreThanFiveYears2024-09-012025-08-31SC572929core:Non-currentFinancialInstruments2025-08-31SC572929core:Non-currentFinancialInstruments2024-08-31SC572929dpl:CostSales2024-09-012025-08-31SC572929dpl:DistributionCosts2024-09-012025-08-31SC572929core:LandBuildings2024-09-012025-08-31SC572929core:PlantMachinery2024-09-012025-08-31SC572929core:Vehicles2024-09-012025-08-31SC572929core:FurnitureFittings2024-09-012025-08-31SC572929core:OfficeEquipment2024-09-012025-08-31SC572929dpl:AdministrativeExpenses2024-09-012025-08-31SC572929core:NetGoodwill2024-09-012025-08-31SC572929core:IntangibleAssetsOtherThanGoodwill2024-09-012025-08-31SC572929dpl:GroupUndertakings2024-09-012025-08-31SC572929dpl:ParticipatingInterests2024-09-012025-08-31SC572929dpl:GroupUndertakingscore:ListedExchangeTraded2024-09-012025-08-31SC572929core:ListedExchangeTraded2024-09-012025-08-31SC572929dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-09-012025-08-31SC572929core:UnlistedNon-exchangeTraded2024-09-012025-08-31SC572929dpl:CostSales2023-09-012024-08-31SC572929dpl:DistributionCosts2023-09-012024-08-31SC572929core:LandBuildings2023-09-012024-08-31SC572929core:PlantMachinery2023-09-012024-08-31SC572929core:Vehicles2023-09-012024-08-31SC572929core:FurnitureFittings2023-09-012024-08-31SC572929core:OfficeEquipment2023-09-012024-08-31SC572929dpl:AdministrativeExpenses2023-09-012024-08-31SC572929core:NetGoodwill2023-09-012024-08-31SC572929core:IntangibleAssetsOtherThanGoodwill2023-09-012024-08-31SC572929dpl:GroupUndertakings2023-09-012024-08-31SC572929dpl:ParticipatingInterests2023-09-012024-08-31SC572929dpl:GroupUndertakingscore:ListedExchangeTraded2023-09-012024-08-31SC572929core:ListedExchangeTraded2023-09-012024-08-31SC572929dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-09-012024-08-31SC572929core:UnlistedNon-exchangeTraded2023-09-012024-08-31SC572929core:NetGoodwill2025-08-31SC572929core:IntangibleAssetsOtherThanGoodwill2025-08-31SC572929core:LandBuildings2025-08-31SC572929core:PlantMachinery2025-08-31SC572929core:Vehicles2025-08-31SC572929core:FurnitureFittings2025-08-31SC572929core:OfficeEquipment2025-08-31SC572929core:AfterOneYear2025-08-31SC572929core:WithinOneYear2025-08-31SC572929core:ListedExchangeTraded2025-08-31SC572929core:UnlistedNon-exchangeTraded2025-08-31SC572929core:ShareCapital2025-08-31SC572929core:SharePremium2025-08-31SC572929core:RevaluationReserve2025-08-31SC572929core:OtherReservesSubtotal2025-08-31SC572929core:RetainedEarningsAccumulatedLosses2025-08-31SC572929core:NetGoodwill2024-08-31SC572929core:IntangibleAssetsOtherThanGoodwill2024-08-31SC572929core:LandBuildings2024-08-31SC572929core:PlantMachinery2024-08-31SC572929core:Vehicles2024-08-31SC572929core:FurnitureFittings2024-08-31SC572929core:OfficeEquipment2024-08-31SC572929core:AfterOneYear2024-08-31SC572929core:WithinOneYear2024-08-31SC572929core:ListedExchangeTraded2024-08-31SC572929core:UnlistedNon-exchangeTraded2024-08-31SC572929core:ShareCapital2024-08-31SC572929core:SharePremium2024-08-31SC572929core:RevaluationReserve2024-08-31SC572929core:OtherReservesSubtotal2024-08-31SC572929core:RetainedEarningsAccumulatedLosses2024-08-31SC572929core:NetGoodwill2023-08-31SC572929core:IntangibleAssetsOtherThanGoodwill2023-08-31SC572929core:LandBuildings2023-08-31SC572929core:PlantMachinery2023-08-31SC572929core:Vehicles2023-08-31SC572929core:FurnitureFittings2023-08-31SC572929core:OfficeEquipment2023-08-31SC572929core:AfterOneYear2023-08-31SC572929core:WithinOneYear2023-08-31SC572929core:ListedExchangeTraded2023-08-31SC572929core:UnlistedNon-exchangeTraded2023-08-31SC572929core:ShareCapital2023-08-31SC572929core:SharePremium2023-08-31SC572929core:RevaluationReserve2023-08-31SC572929core:OtherReservesSubtotal2023-08-31SC572929core:RetainedEarningsAccumulatedLosses2023-08-31SC572929core:AfterOneYear2024-09-012025-08-31SC572929core:WithinOneYear2024-09-012025-08-31SC572929core:Non-currentFinancialInstrumentscore:CostValuation2024-09-012025-08-31SC572929core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-09-012025-08-31SC572929core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-09-012025-08-31SC572929core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-09-012025-08-31SC572929core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-09-012025-08-31SC572929core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-09-012025-08-31SC572929core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-09-012025-08-31SC572929core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-09-012025-08-31SC572929core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-09-012025-08-31SC572929core:Non-currentFinancialInstrumentscore:CostValuation2025-08-31SC572929core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-08-31SC572929core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-08-31SC572929core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-08-31SC572929core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-08-31SC572929core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-08-31SC572929core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-08-31SC572929core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-08-31SC572929core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-08-31SC572929core:Non-currentFinancialInstrumentscore:CostValuation2024-08-31SC572929core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-08-31SC572929core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-08-31SC572929core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-08-31SC572929core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-08-31SC572929core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-08-31SC572929core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-08-31SC572929core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-08-31SC572929core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-08-31SC572929bus:Director12024-09-012025-08-31

THE EYE CLINIC (SCOTLAND) LTD

Registered Number
SC572929
(Scotland)

Unaudited Financial Statements for the Year ended
31 August 2025

THE EYE CLINIC (SCOTLAND) LTD
Company Information
for the year from 1 September 2024 to 31 August 2025

Director

SABOOR, Tariq, Dr

Company Secretary

CHEEMA, Abdur-Rahman Tariq

Registered Address

Darnallan House Blairforkie Drive
Bridge Of Allan
Stirling
FK9 4PE

Registered Number

SC572929 (Scotland)
THE EYE CLINIC (SCOTLAND) LTD
Balance Sheet as at
31 August 2025

Notes

2025

2024

£

£

£

£

Fixed assets
Tangible assets343,57853,804
43,57853,804
Current assets
Debtors4820,844844,301
Cash at bank and on hand1,290,014935,967
2,110,8581,780,268
Creditors amounts falling due within one year5(168,544)(198,464)
Net current assets (liabilities)1,942,3141,581,804
Total assets less current liabilities1,985,8921,635,608
Net assets1,985,8921,635,608
Capital and reserves
Called up share capital100100
Profit and loss account1,985,7921,635,508
Shareholders' funds1,985,8921,635,608
The financial statements were approved and authorised for issue by the Director on 31 May 2026, and are signed on its behalf by:
SABOOR, Tariq, Dr
Director
Registered Company No. SC572929
THE EYE CLINIC (SCOTLAND) LTD
Notes to the Financial Statements
for the year ended 31 August 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in Scotland. The company's registered number and registered office address can be found on the Company Information page.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Functional and presentation currency
The financial statements are presented in sterling and this is the functional currency of the company.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the rendering of services.
Operating leases
Where, substantially, all the risks and rewards of ownership of the asset do not transfer from the lessor to the company, the lease is treated as an operating lease. Rentals payable under operating leases are charged to the profit and loss account on a straight-line basis over the period of the lease.
Employee benefits
Short-term employee benefits are measured at the undiscounted amount expected to be paid in exchange for the employee's services to the company. Where employees have accrued short-term benefits which the entity has not paid by the balance sheet date, an accrual is recognised within creditors: amounts falling due within one year together with an associated expense in profit or loss. The liabilities are classified as current obligations in the statement of financial position because they are expected to be settled wholly within twelve months after the end of the period.
Current taxation
Current tax is recognised in profit or loss, except for taxes related to revaluations of land and buildings which are recognised in other comprehensive income. Current tax represents the amount of tax payable (receivable) in respect of taxable profit (loss) for the current, or past, reporting periods. Current tax is measured at the amount expected to be paid (recovered) using the tax rates and laws which have been enacted, or substantively enacted, by the balance sheet date. Where payments to HM Revenue and Customs exceed liabilities owed, an asset is recognised to the extent of the amount of tax recoverable.
Deferred tax
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Tangible fixed assets and depreciation
Tangible fixed assets are initially recorded at cost and subsequently at cost less depreciation. The depreciation is calculated at the below rates.

Reducing balance (%)
Plant and machinery25
Vehicles25
Office Equipment25
Financial instruments
The company has elected to apply the provisions of Section 11 'Basic Financial Instruments' and Section 12 'Other Financial Instruments Issues' of FRS 102 to all of its financial instruments. Financialinstruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument. Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously. Basic financial assets Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised. Basic financial liabilities Basic financial liabilities, including creditors are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised. Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortized cost using the effective interest method.
Share capital
Ordinary shares are classified as equity. Incremental costs directly attributable to the issue of new ordinary shares or options are shown in equity as a deduction, net of tax, from the proceeds.
2.Average number of employees

20252024
Average number of employees during the year55
3.Tangible fixed assets

Plant & machinery

Vehicles

Office Equipment

Total

££££
Cost or valuation
At 01 September 24-58,695-58,695
Additions2,594-9533,547
At 31 August 252,59458,69595362,242
Depreciation and impairment
At 01 September 24-4,891-4,891
Charge for year10813,45221313,773
At 31 August 2510818,34321318,664
Net book value
At 31 August 252,48640,35274043,578
At 31 August 24-53,804-53,804
4.Debtors: amounts due within one year

2025

2024

££
Other debtors820,844844,301
Total820,844844,301
5.Creditors: amounts due within one year

2025

2024

££
Trade creditors / trade payables6,5323,441
Taxation and social security117,283136,211
Other creditors43,31957,492
Accrued liabilities and deferred income1,4101,320
Total168,544198,464
6.Related party transactions
Included in creditors due within 12 months is an amount of £42,606 (2024: £57,344) due to the director. Included in other debtor is an amount of £67,001 (2024: £67,001) due from Premier Eye Clinic and Laser Centre Ltd, £Nil (2024 : £24,500) due from Glasgow Eye Consultants Ltd; £750,940 (2024: £750,940) due from TR Medic Ltd and £1,284 (2024: Nil) due from Premier Medicare Ltd, companies connected to the director.